Sterile Connecting Device

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institute of Health, Clinical Center (CC) intends to award a Fixed Price Purchase Order to Terumo BCT, Inc. Lakewood, CO 80215 on a sole source basis to procure sterile connecting devices in preparation of highly purified immunotherapy products located at the National Institutes of Health's Clinical Center, Department of Transfusion Medicine.

The Charles S. Carter Cellular Therapy Laboratory uses the sterile connecting devices in the preparation of highly purified unique immunotherapy products for treatment of critically ill patients enrolled in FDA and IRB approved clinical protocols. These instruments are cell separators/washers which are used to separate various blood/blood components from one another. This then permits the specific type of cells of interest to be taken and further manufactured and returned to the patient. This applies to monocytes, as an example can be withdrawn and manufactured into dendritic cells or lymphocytes. The modified lymphocytes can then be reinfused into the patient. Terumo BCT, Inc is the manufacturer of these devices.

This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12 in conjunction with the policies and procedures for the competition requirements in FAR Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Ivan Jones, Contract Specialist, ivan.jones@nih.gov by the due date and time marked in this notice.